Mealey's (September 20, 2017, 9:35 AM EDT) -- ST. LOUIS — An Eighth Circuit U.S. Court of Appeals panel on Sept. 8 reversed and remanded a Baycol whistleblower case, saying a district court misapplied the standard for whether the relator was an original source of information about fraudulent promotion of the cholesterol drug and the filing of false claims to government health care programs (In Re: Baycol Products Litigation, United States of America, ex rel. Laurie Simpson v. Bayer Healthcare, et al., No. 15-2220, 8th Cir., 2017 U.S. App. LEXIS 17371)....